BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 1184740)

  • 21. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal alpha cell function in diabetics response to insulin.
    Unger RH; Madison LL; Muller WA
    Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
    Lawecki J; Symonides-Lawecka A; Rogala H
    Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin.
    Navalesi R; Pilo A; Ferrannini E
    J Clin Invest; 1978 Jan; 61(1):197-208. PubMed ID: 338630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin receptor binding and insulin-mediated glucose uptake in type-II-diabetics.
    Schulz B; Doberne L; Greenfield M; Reaven GM
    Exp Clin Endocrinol; 1983 Jan; 81(1):49-58. PubMed ID: 6343099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting and feeding variations of insulin requirements and insulin binding to erythrocytes at different times of the day in insulin dependent diabetics--assessed under the condition of glucose-controlled insulin infusion.
    Hung CT; Beyer J; Schulz G
    Horm Metab Res; 1986 Jul; 18(7):466-9. PubMed ID: 3527928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of gastric glucagon hypersecretion in insulin-deprived alloxan-diabetic dogs.
    Blazquez E; Muñoz-Barragan L; Patton GS; Dobbs RE; Unger RH
    J Lab Clin Med; 1977 May; 89(5):971-7. PubMed ID: 870572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total pancreatectomy increases the metabolic response to glucagon in humans.
    Bajorunas DR; Fortner JG; Jaspan J; Sherwin RS
    J Clin Endocrinol Metab; 1986 Aug; 63(2):439-46. PubMed ID: 3522619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of glibenclamide treatment on the insulin and glucagon responses to oral glucose and galactose in maturity onset diabetics.
    Hayes JR; Callaghan S; Grant AP
    Diabete Metab; 1979 Sep; 5(3):207-11. PubMed ID: 115730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine interactions.
    Bolli GB; Tsalikian E; Haymond MW; Cryer PE; Gerich JE
    J Clin Invest; 1984 Jun; 73(6):1532-41. PubMed ID: 6373827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.